ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,395.62
-0.34%
Dow Jones
39,806.77
-0.49%
Gold vs US Dollar
2,418.58
-0.33%
Brent Oil
82.865
-0.80%
Bitcoin
70,958.44
-0.69%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) News

GeneDx (WGS)

GeneDx Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:WGS
DateTimeSourceHeadlineSymbolCompany
29/04/202421:05GlobeNewswire Inc.GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/04/202413:30GlobeNewswire Inc.GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetNASDAQ:WGSGeneDx Holdings Corporation
04/04/202421:05GlobeNewswire Inc.GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
14/03/202412:30GlobeNewswire Inc.GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsNASDAQ:WGSGeneDx Holdings Corporation
05/03/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
26/02/202421:05GlobeNewswire Inc.GeneDx to Participate in 44th Annual Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
23/02/202421:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WGSGeneDx Holdings Corporation
20/02/202421:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
20/02/202421:26GlobeNewswire Inc.GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024NASDAQ:WGSGeneDx Holdings Corporation
01/02/202421:30GlobeNewswire Inc.GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 NASDAQ:WGSGeneDx Holdings Corporation
24/01/202421:30GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
23/01/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
08/01/202413:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
08/01/202413:55GlobeNewswire Inc.GeneDx Announces Preliminary 2023 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
04/01/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
03/01/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202302:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202302:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
12/12/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
12/12/202321:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
05/12/202321:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
01/12/202313:30GlobeNewswire Inc.GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with EpilepsyNASDAQ:WGSGeneDx Holdings Corporation
28/11/202321:05GlobeNewswire Inc.GeneDx to Participate in 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:WGSGeneDx Holdings Corporation
20/11/202321:05GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
17/11/202321:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:WGSGeneDx Holdings Corporation
03/11/202320:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
30/10/202320:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
30/10/202320:05GlobeNewswire Inc.GeneDx Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/10/202322:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
09/10/202321:05GlobeNewswire Inc.GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023NASDAQ:WGSGeneDx Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:WGS

Your Recent History

LATK
KLCUSDT
Kalycoin
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved